OMER, Israel, June 24, 2016 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that its flagship medical device, the Medigus Ultrasonic Surgical Endostapler, or MUSEâ„¢ system, continues to gain clinical adoption in the U.S. While procedures are being performed in leading institutions around the country, the Borland-Groover Clinic in Jacksonville, FL continues to lead the number of procedures, most of which are performed by Dr. Ali Lankarani, Board Member, Advanced Therapeutic Endoscopy Center (ATEC) at Borland-Groover Clinic, and MUSE expert.
https://globenewswire.com/news-release/2016/06/24/851200/0/en/Medigus-MUSE-Continues-to-Gain-Clinical-Adoption-in-the-U-S.html
Medigus’ MUSE™ Continues to Gain Clinical Adoption in the U.S.